[SIMEPROP] QoQ TTM Result on 31-Mar-2021 [#1]

Stock
[SIMEPROP] SIME DARBY PROPERTY BERHAD
Announcement Date
27-May-2021
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2021
Quarter
31-Mar-2021 [#1]
Profit Trend
QoQ- 9.7%
YoY- -224.38%
Quarter Report
Latest QR
Upcoming QR
SIMEPROP's Result
SIMEPROP's Financial Summary
View:
Show?
TTM Result
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
Revenue 2,219,924 2,185,743 2,390,131 2,175,531 2,062,781 2,246,522 2,503,927 -7.69%
PBT 268,253 112,442 -205,111 -360,631 -444,710 -266,072 97,404 96.11%
Tax -117,265 -95,508 -120,618 -91,059 -70,973 -80,731 -70,197 40.65%
NP 150,988 16,934 -325,729 -451,690 -515,683 -346,803 27,207 212.47%
-
NP to SH 136,904 8,789 -330,677 -432,348 -478,802 -319,919 60,584 71.94%
-
Tax Rate 43.71% 84.94% - - - - 72.07% -
Total Cost 2,068,936 2,168,809 2,715,860 2,627,221 2,578,464 2,593,325 2,476,720 -11.27%
-
Net Worth 9,181,132 9,045,116 9,181,132 9,181,132 9,113,124 9,181,132 9,453,166 -1.92%
Dividend
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
Div 68,008 68,008 136,016 68,008 68,008 204,025 136,016 -36.92%
Div Payout % 49.68% 773.79% 0.00% 0.00% 0.00% 0.00% 224.51% -
Equity
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
Net Worth 9,181,132 9,045,116 9,181,132 9,181,132 9,113,124 9,181,132 9,453,166 -1.92%
NOSH 6,800,839 6,800,839 6,800,839 6,800,839 6,800,839 6,800,839 6,800,839 0.00%
Ratio Analysis
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
NP Margin 6.80% 0.77% -13.63% -20.76% -25.00% -15.44% 1.09% -
ROE 1.49% 0.10% -3.60% -4.71% -5.25% -3.48% 0.64% -
Per Share
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
RPS 32.64 32.14 35.14 31.99 30.33 33.03 36.82 -7.69%
EPS 2.01 0.13 -4.86 -6.36 -7.04 -4.70 0.89 71.88%
DPS 1.00 1.00 2.00 1.00 1.00 3.00 2.00 -36.92%
NAPS 1.35 1.33 1.35 1.35 1.34 1.35 1.39 -1.92%
Adjusted Per Share Value based on latest NOSH - 6,800,839
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
RPS 32.64 32.14 35.14 31.99 30.33 33.03 36.82 -7.69%
EPS 2.01 0.13 -4.86 -6.36 -7.04 -4.70 0.89 71.88%
DPS 1.00 1.00 2.00 1.00 1.00 3.00 2.00 -36.92%
NAPS 1.35 1.33 1.35 1.35 1.34 1.35 1.39 -1.92%
Price Multiplier on Financial Quarter End Date
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
Date 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 -
Price 0.595 0.655 0.60 0.65 0.665 0.58 0.68 -
P/RPS 1.82 2.04 1.71 2.03 2.19 1.76 1.85 -1.08%
P/EPS 29.56 506.83 -12.34 -10.22 -9.45 -12.33 76.33 -46.77%
EY 3.38 0.20 -8.10 -9.78 -10.59 -8.11 1.31 87.79%
DY 1.68 1.53 3.33 1.54 1.50 5.17 2.94 -31.06%
P/NAPS 0.44 0.49 0.44 0.48 0.50 0.43 0.49 -6.90%
Price Multiplier on Announcement Date
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
Date 24/02/22 25/11/21 26/08/21 27/05/21 25/02/21 25/11/20 26/08/20 -
Price 0.65 0.665 0.63 0.615 0.575 0.58 0.645 -
P/RPS 1.99 2.07 1.79 1.92 1.90 1.76 1.75 8.92%
P/EPS 32.29 514.57 -12.96 -9.67 -8.17 -12.33 72.40 -41.54%
EY 3.10 0.19 -7.72 -10.34 -12.24 -8.11 1.38 71.27%
DY 1.54 1.50 3.17 1.63 1.74 5.17 3.10 -37.19%
P/NAPS 0.48 0.50 0.47 0.46 0.43 0.43 0.46 2.86%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment